| Paclitaxel |
ENSG00000152487.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000157152.12 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000174171.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000175611.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000177112.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000177822.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000177853.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000178412.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000182021.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000182165.13 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000182586.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000184274.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000186615.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000187156.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000187904.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000188365.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000196559.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000196668.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000196951.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000196972.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000203280.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000203593.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000203706.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000203721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000204380.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000204791.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000204949.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000205181.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000205959.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000206142.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000206195.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000213994.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000214145.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000214546.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000214773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000215022.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000215241.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000215447.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000215692.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000215908.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000217258.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000221817.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000223511.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000223571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000223635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000223697.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000223697.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000223745.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000223791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000223834.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000223960.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000223979.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000224081.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000224116.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000224292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000224310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000224424.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000224635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000224707.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000224789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000224812.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000224934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000224934.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000224950.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000224965.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000224977.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000224985.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000224995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000225083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000225177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000225205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000225292.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000225342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000225377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000225393.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000225439.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000225490.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000225578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000225703.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000225762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000225886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000226007.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000226067.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000226137.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000226245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000226287.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000226335.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000226367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000226381.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000226609.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000226752.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000226816.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000226853.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000226862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000226889.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000226917.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000227060.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000227136.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000227220.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000227237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000227279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000227297.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000227354.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000227359.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000227409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000227409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000227431.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000227431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000227533.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000227540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000227540.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000227589.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000227627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000227627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000227698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000227733.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000227741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000228037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000228044.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000228065.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000228084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000228113.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000228150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000228369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000228540.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000228573.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000228661.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000228784.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000228786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000228817.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000228838.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000228886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000228973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000228989.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000229043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000229065.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000229263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000229331.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000229368.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000229431.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000229512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000229688.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000229702.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000229723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000229807.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000229832.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000229852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000229867.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000229931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000229931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000229950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000230021.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000230068.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000230131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000230212.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000230337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000230552.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000230615.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000230732.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000230790.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000230798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000230894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000230912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000230912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000230939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000230943.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000231056.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000231104.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000231104.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000231187.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000231187.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000231233.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000231242.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000231242.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000231298.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000231327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000231355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000231355.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000231566.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000231566.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000231613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000231654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000231654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000231663.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000231705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000231709.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000231709.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000231721.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000231865.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000231976.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000232053.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000232063.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000232065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000232079.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000232082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000232098.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000232116.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000232160.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000232194.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000232211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000232233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000232290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000232412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000232485.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000232527.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000232527.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000232586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000232656.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000232827.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000232855.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000232931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000233006.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233013.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233108.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233137.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233221.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000233223.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000233242.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000233321.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000233330.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233368.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233411.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000233621.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000233665.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233757.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000233757.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000233800.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000233847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233895.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000233937.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000233993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000234136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000234160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000234171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000234378.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000234432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000234492.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000234694.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000234807.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000234818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000234880.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000234945.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000235027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000235070.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000235078.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000235078.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000235106.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000235131.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000235159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000235257.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000235358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000235387.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000235423.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000235437.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000235526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000235586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000235652.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000235740.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000235751.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000235781.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000235806.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000235837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000235884.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000235897.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000235999.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000236051.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000236088.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000236098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000236137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000236144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000236166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000236166.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000236204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000236377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000236434.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000236537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000236663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000236671.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000236751.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000236799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000236869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000236896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000236901.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000236924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000236936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000236943.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000236986.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000236991.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000237021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000237125.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000237159.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000237248.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000237253.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000237298.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000237301.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000237505.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000237520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000237737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000237753.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000237781.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000237813.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000237819.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000237870.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000237940.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000238005.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000238058.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000238113.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000238113.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000238198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000239213.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000239219.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000239523.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000239705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000239945.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000240057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000240063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000240618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000240618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000240859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000240996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000240996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000241125.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000241269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000241316.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000241520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000241572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000241770.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000241860.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000242086.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000242136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000242242.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000242553.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000243069.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000243224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000243533.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000243766.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000243926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000244036.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000244063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000244184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000244198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000244265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000244306.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000244479.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000244578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000244586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000244733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000244998.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000245059.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000245322.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000245498.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000245532.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000245556.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000245748.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000246250.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000246323.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000246548.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000246792.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000247092.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000247092.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000247363.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000247373.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000247400.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000247595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000247774.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000248103.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000248131.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000248150.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000248206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000248473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000248664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000248774.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000248858.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000248896.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000248927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000249198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000249252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000249306.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000249348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000249436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000249604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000249655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000249740.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000249753.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000249898.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000250015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000250061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000250073.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000250220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000250295.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000250312.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000250320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000250326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000250404.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000250404.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000250410.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000250519.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000250608.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000250659.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000250765.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000250899.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000250900.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000251018.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000251127.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000251175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000251442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000251555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000251556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000251629.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000251675.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000251867.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000253112.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000253121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000253307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000253339.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000253390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000253553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000253632.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000253712.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000253730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000253737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000253744.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000253819.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000253854.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000253911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000253921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000253921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000253930.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000253948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000253955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000253986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000254057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000254099.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000254224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000254226.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000254226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000254389.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000254401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000254542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000254592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000254694.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000254762.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000254821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000254842.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000254855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000254855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000254859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000254869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000254966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000254985.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000254990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000255121.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000255142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000255164.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000255176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000255182.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000255306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000255320.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000255348.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000255354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000255367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000255455.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000255474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000255509.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000255520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000255557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000255670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000255741.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000255790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000255933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000255970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000256001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000256150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000256250.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000256546.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000256712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000256894.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000256967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000257004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000257135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000257193.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000257605.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000257702.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000257830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000257845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000257900.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000257910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000257931.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000258102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000258301.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000258314.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000258317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000258410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000258437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000258458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000258553.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000258558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000258658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000258725.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000258789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000258935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000258942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000258999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259062.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000259065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000259225.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000259244.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000259310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000259343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000259349.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000259372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000259438.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259438.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000259442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259448.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000259523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000259540.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000259668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000259705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000259709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000259715.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000259767.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259768.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259771.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000259783.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000259786.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000259796.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000259826.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000259840.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259877.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259877.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000259883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000259933.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260018.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000260032.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000260081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000260083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000260158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000260185.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260276.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000260281.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000260306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000260360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000260388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000260468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260475.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000260528.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000260589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000260604.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000260630.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000260672.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000260693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000260742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000260743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000260766.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000260787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260790.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000260805.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000260871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000260871.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000260891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000260941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000260949.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000260973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000260988.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000261043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000261064.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000261094.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000261096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000261159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000261188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000261251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000261266.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000261302.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000261327.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000261428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000261433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000261471.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000261488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000261504.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000261520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000261572.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000261574.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000261616.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000261670.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000261695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000261712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000261786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000261824.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000261886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000262115.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000262185.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000262222.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000262298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000262339.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000262339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000262434.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000262652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000262714.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000262823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000262903.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000262999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000263004.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000263013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000263280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000263327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000263338.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000263350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000263412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000263470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000263531.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000263745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000263766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000263847.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000263862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000263884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000263924.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000264448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000264448.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000264575.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000264769.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000264859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000264860.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000264932.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000264932.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000264940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000265091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000265113.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000265142.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000265334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000265394.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000265443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000265445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000265445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000265451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000265780.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000265791.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000266236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000266411.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000266538.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000266598.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000266729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000266904.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000266941.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000266942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000266970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000267009.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000267025.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000267053.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000267067.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000267082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000267093.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000267138.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000267169.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000267192.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000267221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000267248.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000267248.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000267265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000267298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000267322.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000267344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000267347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000267348.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000267475.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000267581.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000267759.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000267787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000267858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000267871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000267898.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000267904.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000267905.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000267919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000268262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000268364.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000268471.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000268584.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000268746.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000268764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000268987.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000269038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000269051.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000269161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000269194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000269399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000269399.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000269427.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000269646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000269737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000269896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000269959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000269966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000270039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000270048.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000270062.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000270066.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000270091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000270102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000270109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000270482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000270996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000271133.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000271151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000271324.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000271359.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000271401.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000271631.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000271716.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000271734.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000271743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000271751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000271755.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000271788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000271825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000271851.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000271882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000271912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000271966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000271996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000272009.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272029.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000272033.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000272138.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000272138.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272156.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000272254.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000272264.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272320.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000272327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272338.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272341.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272346.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272354.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272369.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000272389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272420.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272498.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272508.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272518.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000272524.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272524.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272562.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272562.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272574.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000272660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272695.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272702.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272754.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000272764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000272782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272788.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272812.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Paclitaxel |
ENSG00000272895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000272940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000272953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000272954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000272966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000272995.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000273008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000273044.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000273117.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000273139.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
ENSG00000273230.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Paclitaxel |
ENSG00000273230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000273243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000273243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000273245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000273309.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Paclitaxel |
ENSG00000273353.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000273396.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Paclitaxel |
ENSG00000273402.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Paclitaxel |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Paclitaxel |
ENSG00000273449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Paclitaxel |
hs-160 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
hs-188 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
hs-254 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
hs-279-a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
hs-303-b |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
hsa-1274A |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
hsa-miRPlus-A1098 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
hsa-miRPlus-C1005 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
hsa-miRPlus-C1040 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
hsa-miRPlus-C1049 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
hsa-miRPlus-C1100 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
let-7 |
Curated miRNA |
hepatocellular carcinoma |
|
| Paclitaxel |
let-7 |
Curated miRNA |
KRAS mutation cancer |
|
| Paclitaxel |
let-7 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
let-7a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
let-7a |
Curated miRNA |
hepatocellular carcinoma |
|
| Paclitaxel |
let-7a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
let-7a |
Curated miRNA |
squamous carcinoma |
|
| Paclitaxel |
let-7b |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
let-7b |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
let-7d |
Curated miRNA |
oral cancer |
|
| Paclitaxel |
let-7e |
Curated miRNA |
Cancer |
|
| Paclitaxel |
let-7e |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
let-7g |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
let-7i |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
let-7i |
Curated miRNA |
ovarian carcinoma |
|
| Paclitaxel |
miR-1 |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-100 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-100 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-101 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-103-2* |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-106 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-106a |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-106a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-106a |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-106a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-106b |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-106b |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-106b* |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-106b-25 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-107 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-10a |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-10a |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-10b |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-10b |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-1197 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-1200 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-1204 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-1204 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-124* |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-1246 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-1250 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-125a |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-125a |
Curated miRNA |
colon cancer |
|
| Paclitaxel |
miR-125a |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-125a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-125b |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-125b |
Curated miRNA |
colon cancer |
|
| Paclitaxel |
miR-125b |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-125b |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-125b |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-126 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-126 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-126 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-126 |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-1264 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-1265 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-1268 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-127 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-1275 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-1277 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-128 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-128 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-1287 |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-128a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-129 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-1290 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-1290 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-1291 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-1296 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-130a |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-130a |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-130a |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-130a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-130a |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-130b |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-130b |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-130b* |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-130b* |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-132 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-133a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Paclitaxel |
miR-133a |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-133b |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Paclitaxel |
miR-133b |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-133b |
Curated miRNA |
ovarian carcinoma |
|
| Paclitaxel |
miR-134 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-134 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-135a |
Curated miRNA |
non-small cell lung carcinoma |
|
| Paclitaxel |
miR-135b |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-137 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-137 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-138 |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-139 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-140 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-140 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-141 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-141 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-142 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-143 |
Curated miRNA |
colorectal cancer |
|
| Paclitaxel |
miR-143 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-143* |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-144 |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-145 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-145* |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-146a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-146a |
Curated miRNA |
epithelial ovarian cancer |
|
| Paclitaxel |
miR-146a |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-146a |
Curated miRNA |
tumorigenic mammary stem cell |
|
| Paclitaxel |
miR-146b |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-148a |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-148a |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-149 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-149 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-155 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-155 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-155 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-155 |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-155* |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-15a |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-15b |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-16 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-16 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-16 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-17 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-17 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-17 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-17 |
Curated miRNA |
ovarian carcinoma |
|
| Paclitaxel |
miR-17 |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-181a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-181a-2* |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-181b |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-181c |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-182 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-182 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-187 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-187 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-188 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-18a |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-18a* |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-19 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-1908 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-191 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-192 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-193a |
Curated miRNA |
bladder cancer |
|
| Paclitaxel |
miR-193b |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-193b |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-193b* |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-193b* |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-194 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-195 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-195 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-195 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-197 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-1973 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-199a |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-199a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-19a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-19a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-19a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-19b |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-200 |
Curated miRNA |
ovarian carcinoma |
|
| Paclitaxel |
miR-200a |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-200a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-200b |
Curated miRNA |
melanoma |
|
| Paclitaxel |
miR-200b* |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-200c |
Curated miRNA |
endometrial cancer |
|
| Paclitaxel |
miR-200c |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-200c |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-200c |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-200c |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-203 |
Curated miRNA |
colon cancer |
|
| Paclitaxel |
miR-204 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-205 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-205 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-208b |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-20a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-20b |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-20b |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-20b* |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-21 |
Curated miRNA |
- |
|
| Paclitaxel |
miR-21 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-21 |
Curated miRNA |
breast carcinoma |
|
| Paclitaxel |
miR-21 |
Curated miRNA |
epithelial ovarian cancer |
|
| Paclitaxel |
miR-21 |
Curated miRNA |
glioblastoma |
|
| Paclitaxel |
miR-21 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-210 |
Curated miRNA |
cervical cancer |
|
| Paclitaxel |
miR-210 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-2114 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-213 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-214 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-217 |
Curated miRNA |
melanoma |
|
| Paclitaxel |
miR-217 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-218 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-218 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-218 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-219-2 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-22 |
Curated miRNA |
colon cancer |
|
| Paclitaxel |
miR-22 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-22 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-221 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-221 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-222 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-223 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-223 |
Curated miRNA |
hepatocellular carcinoma |
|
| Paclitaxel |
miR-224 |
Curated miRNA |
cervical cancer |
|
| Paclitaxel |
miR-224 |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-224* |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-2277 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-2278 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-23b |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-23b |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-23b |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-23c |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-25 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-26a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-27a |
Curated miRNA |
bladder cancer |
|
| Paclitaxel |
miR-27a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-27a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-27a |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-27b |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-28 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-28 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-296 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-296 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-2964a |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-29a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-29b |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-29b |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-29b |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-29c |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-29c |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-301a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-302b* |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-302d |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-3065 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3074 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3074 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-30a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-30a |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-30a |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-30a* |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-30b |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-30c |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-30c |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-30c |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-30c |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-31* |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-31* |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-3127 |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-3144 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3146 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-3150b |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3153 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3161 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3163 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3164 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3167 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3168 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3173 |
Curated miRNA |
laryngeal cancer |
|
| Paclitaxel |
miR-3196 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-3198 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-32 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-320 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-320a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-321 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-326 |
Curated miRNA |
melanoma |
|
| Paclitaxel |
miR-330 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-331 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-335 |
Curated miRNA |
cancer |
|
| Paclitaxel |
miR-335 |
Curated miRNA |
melanoma |
|
| Paclitaxel |
miR-335 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-337 |
Curated miRNA |
non-small cell lung cancers |
|
| Paclitaxel |
miR-338 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-342 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-342 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-346 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-34a |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-34a |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-34c |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-34c |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-361 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-363 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-363 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-365 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-367 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-373 |
Curated miRNA |
prostate cancer |
|
| Paclitaxel |
miR-373* |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-374 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-374-a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-375 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-375 |
Curated miRNA |
cervical cancer |
|
| Paclitaxel |
miR-376a* |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-376b |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-377 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-377 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-411 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-424* |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-4284 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-4288 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-433 |
Curated miRNA |
serous epithelial ovarian cancer |
|
| Paclitaxel |
miR-4478 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-452 |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-452-AS |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-4653 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-4678 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-4713 |
Curated miRNA |
gastric cancer |
|
| Paclitaxel |
miR-4788 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-483 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-483 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-484 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-489 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-490 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-491 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-497 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-513a |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-515 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-516 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-517* |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-520h |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-589 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-591 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-592 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-605 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-610 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-615 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-620 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-622 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-625* |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-634 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-640 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-642 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-647 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-653 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-663 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-671 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-671 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-676* |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-7 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-7 |
Curated miRNA |
non-small cell lung cancer |
|
| Paclitaxel |
miR-744 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-767 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-768 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-769 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-801 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-802 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Paclitaxel |
miR-875 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-885 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-9 |
Curated miRNA |
ovarian cancer |
|
| Paclitaxel |
miR-920 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-922 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-923 |
Curated miRNA |
breast cancer |
|
| Paclitaxel |
miR-923 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-933 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-938 |
Curated miRNA |
lung cancer |
|
| Paclitaxel |
miR-95 |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miR-96 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
miR-99b |
Curated miRNA |
Cancer |
|
| Paclitaxel |
miRPlus-A1086 |
Curated miRNA |
lung adenocarcinoma |
|
| Paclitaxel |
PVT1 |
Curated lncRNA |
gastric cancer |
|
| Paclitaxel |
XIST |
Curated lncRNA |
ovarian cancer |
|